Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd D Armstrong

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Surgical Oncology Clinics of North America|December 19, 2002
Cytokine modified tumor vaccinesTodd D Armstrong, Elizabeth M Jaffee
Cancer Immunology Research|April 26, 2014
Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized miceChelsea M Black, Todd D Armstrong, Elizabeth M Jaffee
Cancer Immunology Research|January 11, 2014
Tumor immunology: multidisciplinary science driving basic and clinical advancesBridget P Keenan, Elizabeth M Jaffee, Todd D Armstrong
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunopreventionNina J Chu, Todd D Armstrong, Elizabeth M Jaffee
Clinical and Translational Science|April 2, 2010
Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinomaIhid C Leao, Priya Ganesan, Todd D Armstrong, et al.
Cancer Immunology Research|May 14, 2015
Special Conference on Tumor Immunology and Immunotherapy: A New ChapterKatelyn T Byrne, Robert H Vonderheide, Elizabeth M Jaffee, et al.
Oncoimmunology|November 22, 2012
Targeting the right regulatory T-cell population for tumor immunotherapyVivian L Weiss, Timothy H Lee, Elizabeth M Jaffee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanismsSara Gandini, Albert B Lowenfels, Elizabeth M Jaffee, et al.
Cellular Immunology|March 30, 2010
Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in miceLukas W Pfannenstiel, Samuel S K Lam, Leisha A Emens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2011
Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune responseJennifer N Uram, Chelsea M Black, Emilee Flynn, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Surgical Oncology Clinics of North America|December 19, 2002
Cytokine modified tumor vaccinesTodd D Armstrong, Elizabeth M Jaffee
Cancer Immunology Research|April 26, 2014
Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized miceChelsea M Black, Todd D Armstrong, Elizabeth M Jaffee
Cancer Immunology Research|January 11, 2014
Tumor immunology: multidisciplinary science driving basic and clinical advancesBridget P Keenan, Elizabeth M Jaffee, Todd D Armstrong
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunopreventionNina J Chu, Todd D Armstrong, Elizabeth M Jaffee
Clinical and Translational Science|April 2, 2010
Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinomaIhid C Leao, Priya Ganesan, Todd D Armstrong, et al.
Cancer Immunology Research|May 14, 2015
Special Conference on Tumor Immunology and Immunotherapy: A New ChapterKatelyn T Byrne, Robert H Vonderheide, Elizabeth M Jaffee, et al.
Oncoimmunology|November 22, 2012
Targeting the right regulatory T-cell population for tumor immunotherapyVivian L Weiss, Timothy H Lee, Elizabeth M Jaffee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanismsSara Gandini, Albert B Lowenfels, Elizabeth M Jaffee, et al.
Cellular Immunology|March 30, 2010
Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in miceLukas W Pfannenstiel, Samuel S K Lam, Leisha A Emens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2011
Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune responseJennifer N Uram, Chelsea M Black, Emilee Flynn, et al.
Pageof 5